Fundraising Fox
Gen Incode
Oxford, GB · 2 known investors
Find your way into Gen Incode
Sign up to see every warm intro you have to Gen Incode
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Gen Incode team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
GENinCode provides genomic testing for cardiovascular disease prevention and diagnosis using monogenic and polygenic risk assessment to identify patient risk and enable targeted preventive treatment. The company also offers testing for ovarian cancer surveillance, leveraging its proprietary software platform to combine genetic profiles with clinical risk factors.
Investors · 2
Frequently asked questions
- What does Gen Incode do?
- GENinCode provides genomic testing for cardiovascular disease prevention and diagnosis using monogenic and polygenic risk assessment to identify patient risk and enable targeted preventive treatment. The company also offers testing for ovarian cancer surveillance, leveraging its proprietary software platform to combine genetic profiles with clinical risk factors.
- Who are Gen Incode's investors?
- Gen Incode's investors include Maven Capital Partners, Cambridge Innovation Capital.
- Where is Gen Incode headquartered?
- Gen Incode is headquartered in Oxford, GB.